PAVmed- Warrants (29/01/2022) Profit Margin

PAVmed- Warrants (29/01/2022) posts a profit margin of -49188.29% as of June 2026. That compares with 6802.35% in the prior-year period — down 823.1% year over year. That is below the Healthcare sector average of 13.89%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, PAVmed- Warrants (29/01/2022)'s profit margin was 6802.35%. The latest reading is -49188.29% — a 823.1% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 13.89% is typical. PAVmed- Warrants (29/01/2022)'s -49188.29% is lower that level. That is roughly 354148.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

PAVmed- Warrants (29/01/2022)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -49188.29% as of June 2026; use YoY and peer views to separate noise from signal.

Context for PAVMW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.89%), and (3) consistency with growth and profitability. This page covers the first two; PAVmed- Warrants (29/01/2022)'s other metric pages and overview cover the third.